PMV Pharmaceuticals, Inc.
PMVP
$1.56
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/16/2026
-
MarketBeat
3/12/2026
-
TipRanks Financial Blog
3/8/2026
-
Ticker Report
3/8/2026
-
MarketBeat
3/6/2026
-
The Fly
3/6/2026
-
Globe Newswire
3/4/2026
-
MarketBeat
2/26/2026
-
The Fly
2/26/2026
-
Globe Newswire
2/23/2026
-
MarketBeat
2/19/2026
-
MarketBeat
1/28/2026
-
Simply Wall St
1/28/2026
-
MarketBeat
1/1/2026
-
MarketBeat
12/9/2025
-
MarketBeat
11/17/2025
-
MarketBeat
11/15/2025
-
GuruFocus
11/14/2025
-
MarketBeat
11/12/2025
-
GuruFocus
11/12/2025
-
The Fly
11/12/2025
-
Globe Newswire
11/3/2025
-
Simply Wall St
11/1/2025
-
MarketBeat
10/31/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, March 6, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 4 and 8 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
609 642 6670
Address
400 Alexander Park Drive
Princeton, NJ 08540
Princeton, NJ 08540
Country
Year Founded
Business Description
Sector
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United...
more